Sophia Genetics SA (STU:90B)
€ 3.44 0.42 (13.91%) Market Cap: 235.02 Mil Enterprise Value: 175.18 Mil PE Ratio: 0 PB Ratio: 2.06 GF Score: 56/100

Q1 2024 Sophia Genetics SA Earnings Call Transcript

May 07, 2024 / 12:00PM GMT
Release Date Price: €4.62 (+3.59%)
Operator

Good day, everyone. My name is Jamie, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Sophia Genetics first-quarter 2024 earnings conference call. (Operator Instructions) Also note, today's event is being recorded.

At this time, I'd like to turn the floor over to Kellen Sanger, Sophia Genetics' Head of Strategy and Investor Relations. You may begin.

Kellen Sanger
Sophia Genetics SA - Head of Strategy and Investor Relations

Thank you, and good morning, everyone. Welcome to the Sophia Genetics' first-quarter 2024 earnings conference call. Joining me today to discuss our results are Dr. Jurgi Camblong, our Co-Founder and Chief Executive Officer; and Ross Muken, our Chief Financial Officer and Chief Operating Officer.

I'd like to remind you that management will make statements during this call that are forward-looking statements within the meanings of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot